Issue 1/2018
Content (20 Articles)
High-intensity exercise interventions in cancer survivors: a systematic review exploring the impact on health outcomes
Kellie Toohey, Kate Pumpa, Andrew McKune, Julie Cooke, Stuart Semple
The G protein-coupled estrogen receptor (GPER/GPR30) may serve as a prognostic marker in early-stage cervical cancer
Klaus Friese, Bernd Kost, Aurelia Vattai, Frederik Marmé, Christina Kuhn, Sven Mahner, Christian Dannecker, Udo Jeschke, Sabine Heublein
Pathological significance and prognostic significance of FES expression in bladder cancer vary according to tumor grade
Akihiro Asai, Yasuyoshi Miyata, Kosuke Takehara, Shigeru Kanda, Shin-ichi Watanabe, Peter A. Greer, Hideki Sakai
A revision of the Tokuhashi revised score improves the prognostic ability in patients with metastatic spinal cord compression
Søren Schmidt Morgen, Sidsel Fruergaard, Martin Gehrchen, Sebastian Bjørck, Svend Aage Engelholm, Benny Dahl
Cannabinoid receptor 2 as a novel target for promotion of renal cell carcinoma prognosis and progression
Jianfeng Wang, Yunze Xu, Liangsong Zhu, Yun Zou, Wen Kong, Baijun Dong, Jiwei Huang, Yonghui Chen, Wei Xue, Yiran Huang, Jin Zhang
Prevalence of fibroblast growth factor receptor 1 (FGFR1) amplification in squamous cell carcinomas of the head and neck
Till Sebastian Clauditz, Arne Böttcher, Henning Hanken, Kerstin Borgmann, Guido Sauter, Waldemar Wilczak, Tobias Grob, Adrian Münscher
Differences in the prognosis of HPV16-positive patients with squamous cell carcinoma of head and neck according to viral load and expression of P16
Beata Biesaga, Anna Mucha-Małecka, Anna Janecka-Widła, Marta Kołodziej-Rzepa, Sława Szostek, Dorota Słonina, Aleksandra Kowalczyk, Krzysztof Halaszka, Marcin Przewoźnik
Molecular alterations in a new cell line (KU-Lu-MPPt3) established from a human lung adenocarcinoma with a micropapillary pattern
Yukiko Matsuo, Kazu Shiomi, Dai Sonoda, Masashi Mikubo, Masahito Naito, Yoshio Matsui, Tsutomu Yoshida, Yukitoshi Satoh
Additive naftopidil treatment synergizes docetaxel-induced apoptosis in human prostate cancer cells
Kenichiro Ishii, Izumi Matsuoka, Shinya Kajiwara, Takeshi Sasaki, Manabu Miki, Manabu Kato, Hideki Kanda, Kiminobu Arima, Taizo Shiraishi, Yoshiki Sugimura
Cardiovascular effects of Hodgkin’s lymphoma: a review of literature
Aasems Jacob, Bragadheeswar Thyagarajan, Monisha Priyadarshini Kumar, Nasreen Shaikh, David Sharon
The usefulness of testosterone administration in identifying false-positive elevation of serum human chorionic gonadotropin in patients with germ cell tumor
Akitoshi Takizawa, Koji Kawai, Takashi Kawahara, Takahiro Kojima, Satoru Maruyama, Nobuo Shinohara, Shusuke Akamatsu, Tomomi Kamba, Terukazu Nakamura, Osamu Ukimura, Ryosuke Jikuya, Takeshi Kishida, Kenichi Kakimoto, Kazuo Nishimura, Toru Harabayashi, Satoshi Nagamori, Shinichi Yamashita, Yoichi Arai, Yoshitomo Sawada, Noritoshi Sekido, Hidefumi Kinoshita, Tadashi Matsuda, Tohru Nakagawa, Yukio Homma, Hiroyuki Nishiyama
Lung cancer screening with MRI: results of the first screening round
Michael Meier-Schroers, Rami Homsi, Dirk Skowasch, Jens Buermann, Matthias Zipfel, Hans Heinz Schild, Daniel Thomas
Safety study and therapeutic drug monitoring of the oral tablet formulation of posaconazole in patients with haematological malignancies
C. Boglione-Kerrien, S. Picard, C. Tron, S. Nimubona, J.-P. Gangneux, S. Lalanne, F. Lemaitre, E. Bellissant, M.-C. Verdier, A. Petitcollin
A novel biopsy-related parameter derived from location and relationship of positive cores on standard 12-core trans-rectal ultrasound-guided prostate biopsy: a useful parameter for predicting tumor volume compared to number of positive cores
Sangjun Yoo, Hwancheol Son, Sohee Oh, Juhyun Park, Sung Yong Cho, Min Chul Cho, Hyeon Jeong
Causes of death and competing risk analysis of the associated factors for non-small cell lung cancer using the Surveillance, Epidemiology, and End Results database
Shenhai Wei, Jintao Tian, Xiaoping Song, Bingqun Wu, Limin Liu
Drug-eluting bead transarterial chemoembolization in the treatment for unresectable soft tissue sarcoma refractory to systemic chemotherapy: a preliminary evaluation of efficacy and safety
Jia-yan Ni, Hong-liang Sun, Yao-ting Chen, Jiang-hong Luo, Wei-dong Wang, Xiong-ying Jiang, Dong Chen, Lin-feng Xu
Are exon 19 deletions and L858R different in early stage lung adenocarcinoma?
Yiliang Zhang, Yuan Ma, Yuan Li, Xuxia Shen, Yongfu Yu, Yunjian Pan, Yang Zhang, Su Yu, Difan Zheng, Yue Zhao, Hong Hu, Yihua Sun, Yawei Zhang, Jiaqing Xiang, Haiquan Chen
Qualitative evaluation of mobile cancer apps with particular attention to the target group, content, and advertising
Cathleen Böhme, Marc Baron von Osthoff, Katrin Frey, Jutta Hübner
Can checkpoint inhibitor therapy improve response to chemotherapy?
Michael Constantin Kirchberger, Bastian Schilling, Sebastian Haferkamp, Anja Bosserhoff, Gerold Schuler, Lucie Heinzerling
Correction to: An analysis of the kinetics of molecular response during the first trimester of treatment with nilotinib in newly diagnosed chronic myeloid leukemia patients in chronic phase
Juan Luis Steegmann, Dolors Colomer, Maria-Teresa Gómez-Casares, Valentín García-Gutiérrez, Guillermo Ortí, Angel Ramírez-Payer, Eduardo Olavarria, Ferrán Vall-llovera, Pilar Giraldo, Eulogio Conde, Rolando Vallansot, Jose Luis López-Lorenzo, Luis Palomera, Alberto Álvarez-Larrán, Venancio Conesa, Guiomar Bautista, Laura Casas, Frank Giles, Andreas Hochhaus, Luis Felipe Casado-Montero